BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) — Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross proceeds to Legend Biotech from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Legend Biotech, are expected to be approximately $226 million,...

MOUNTAINSIDE, N.J., June 17, 2026 (GLOBE NEWSWIRE) — Yorkville International Capital Corp. (the “Company”) announced today that it closed its initial public offering of 23,000,000 units, including the issuance of 3,000,000 units as result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per unit. The gross proceeds from the offering were $230 million before deducting underwriting discounts and estimated offering expenses. The units began trading on the Global Market tier of The Nasdaq Stock Market (“Nasdaq”) under the ticker symbol “YICCU” on June 16, 2026. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share of the Company at a price of $11.50 per share,...

TORONTO, June 17, 2026 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced the results of matters voted on at its annual and special meeting (the “Meeting”) of holders of common shares (“Shareholders”) held today. There were 389 Shareholders represented virtually or by proxy at the Meeting holding an aggregate of 130,357,074 common shares, representing 30.68% of MediPharm’s total issued and outstanding common shares as of the record date for the Meeting. As the Meeting was held virtually, all resolutions were passed by way of ballot. Complete voting results for each of the matters presented at the Meeting are provided below. Board Changes Following his re-election as a...

VANCOUVER, British Columbia, June 17, 2026 (GLOBE NEWSWIRE) — Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) (“Liberty Gold” or the “Company”) announces voting results from the Company’s Annual General Meeting of Shareholders held on June 17, 2026 (the “Meeting”). Mr. Rob Pease, who has served on the Board of Liberty Gold for approximately 15 years, including a period as Chair of the Board, did not stand for re-election as a director at the Meeting. Mr. Pease has played a key role in guiding the Company through multiple stages of its development and will remain engaged with Liberty Gold in an advisory capacity as Corporate Advisor, ensuring continued access to his experience and perspective. On behalf of the Board and management team, Liberty Gold extends its sincere appreciation to Mr. Pease for his longstanding service, leadership,...

GONZALES, La., June 17, 2026 (GLOBE NEWSWIRE) — Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”), a producer, designer, and distributor of infant, toddler, and juvenile consumer products, today announced that it will release the results of its operations for the fourth quarter and full year fiscal 2026 before the market opens on Wednesday, June 24, 2026. Olivia W. Elliott, President and Chief Executive Officer, and Claire K. Spencer, Vice President and Chief Financial Officer, will host a teleconference at 8:00 a.m. Central Time on that day to discuss the Company’s results. Interested individuals may join the teleconference by dialing (844) 539-3703 or (412) 652-1273 and asking to join the Crown Crafts, Inc. call. The teleconference can also be accessed in listen-only mode by visiting the Company’s website at www.crowncrafts.com....

TORTOLA, British Virgin Islands, June 17, 2026 (GLOBE NEWSWIRE) — Orca Energy Group Inc. (“Orca” or the “Company”) (TSX-V: ORC.A, ORC.B) is pleased to announce the voting results from its annual general and special meeting of shareholders held on June 17, 2026 (the “Meeting“) and that the previously disclosed management cease trade order (the “MCTO“) against the securities of Orca for each of Jay Lyons and Lisa Mitchell issued by the Alberta Securities Commission pursuant to National Policy 12-203 Management Cease Trade Orders (“NP 12-203“) on May 1, 2026,  is no longer in effect. The Company rectified its defaults pursuant to the MCTO and NP 12-203 on June 5, 2026, and the MCTO is no longer in effect as of June 10, 2026. The results from the Meeting for each of the resolutions in the Company’s...

Acquisition adds multiple immunology assets to Biogen’s portfolio, including a lead asset poised to enter Phase 1 development CAMBRIDGE, Mass. and SAN DIEGO, June 17, 2026 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) and RayThera Inc., a private biotechnology company focused on discovering and developing small molecule therapies in immunology, today announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire RayThera Inc. for up to $1 billion, consisting of an upfront payment and, predominantly, payments contingent on the achievement of future clinical and regulatory milestones. RayThera’s portfolio includes multiple anti-inflammatory assets that could potentially treat immune-mediated conditions across a range of indications. The lead candidate is expected to enter Phase 1 development...

Oslo, 18 June 2027: Reference is made to the stock exchange announcement published by Zelluna ASA (the “Company”) on 17 June 2026 regarding completion of a placement of 3 143 958 new shares at a subscription price of NOK 18.50 (the “Subscription Price”) per new share (the “Private Placement”). Radforsk Investeringsstiftelse, a foundation closely associated with Anders Tuv (Chairman of the Board of the Company), has been allocated 162 162 shares in the Private Placement at the Subscription Price. In addition, and to facilitate delivery-versus-payment (“DVP”) settlement of shares allocated to investors in the Private Placement, Radforsk Investeringsstiftelse has, pursuant to a share lending agreement, agreed to lend out 2 469 693 existing and unencumbered shares in the Company to ABG Sundal...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Zelluna ASA: Private Placement and Retail Offering successfully placedPrivate Placement and Retail Offering successfully completed, raising gross proceeds of approximately NOK 58.2 million Financing intended to strengthen Zelluna’s position as the Company approaches initial clinical data and enhance financial flexibility to pursue future strategic opportunities Advancing ZI-MA4-1, the world’s first MAGE-A4-targeting off-the-shelf TCR-NK therapy in clinical development On...

TAMPA, Fla., June 17, 2026 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE: HCI) today announced the launch of a pilot project featuring digital tokenized reinsurance securities offering contractual returns that mirror the performance of specific participations by its Cayman Islands-based reinsurance subsidiary, Fortex Reinsurance SPC, Ltd. (“Fortex Re”), in HCI’s catastrophe excess-of-loss reinsurance programs. HCI is launching this pilot project to explore new ways to expand investor access to catastrophe risk as an asset class. “We are pioneering a new method of risk transfer by connecting the reinsurance market with new sources of capital,” said Paresh Patel, HCI’s Chairman and Chief Executive Officer. “While still in its early stages, we believe tokenized reinsurance securities have the potential to expand access...